/Companies

CellPly

Bologna, IT · Founded 2013 · 28 employees on LinkedIn · 3 known investors

Find your way into CellPly

Sign up to see every warm intro you have to CellPly

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CellPly team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution. It serves cell therapy discovery and development teams, measuring phenotype and function across thousands of single-cell co-cultures and comparing up to 128 conditions per run.

Founders & leadership

CellPly was founded in 2013 by Massimo Bocchi.

MBMassimo Bocchi
Massimo BocchiCo-Founder & Chief Operating OfficerHe has spent over a decade in life science technology development, with research and publication record in microtechnologies for cell analysis, and holds multiple patents in the field. He has led commercialization efforts for deep tech platforms integrating microfluidics, robotics, and AI for biopharma and research institutions, and coordinated European research funding initiatives.
AZAlessia Zanelli
Alessia ZanelliPresident & CEOZanelli previously served as General Manager of Comecer, an Italian healthcare-sector manufacturer, following the company's 2019 acquisition by Canadian industrial group ATS. She subsequently established a holding company in Milan focused on early-stage investing and has been involved with multiple health-tech startups including Cellply.
AFAndrea Faenza
Andrea FaenzaChief Technology Officer

Investors · 3

Frequently asked questions

What does CellPly do?
Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution. It serves cell therapy discovery and development teams, measuring phenotype and function across thousands of single-cell co-cultures and comparing up to 128 conditions per run.
Who founded CellPly?
CellPly was founded by Massimo Bocchi in 2013.
Who are CellPly's investors?
CellPly's investors include Indaco Venture Partners, Italian Angels for Growth, LIFTT.
Where is CellPly headquartered?
CellPly is headquartered in Bologna, IT.